NOA-12: BIBF1120 and R-RT in Glioblastoma

NCT01666600 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

63

Enrollment

OTHER

Sponsor class

Stopped Interim Analysis for Feasibility

Conditions

Glioblastoma Multiforme

Interventions

DRUG: BIBF 1120
RADIATION: radiotherapy

Sponsor

Prof. Dr. Wolfgang Wick